The nurse is caring for an infant diagnosed with Hirschsprung disease who is awaiting surgery

  1. Langer JC. Hirschsprung disease. Curr Opin Pediatr. 2013;25:368–74.

    PubMed  Google Scholar 

  2. Neuvonen MI, Kyrklund K, Lindahl HG, et al. A population-based, complete follow-up of 146 consecutive patients after transanal mucosectomy for Hirschsprung’s disease. J Pediatr Surg. 2015;50:1653–8.

    PubMed  Google Scholar 

  3. European Commission: European Reference Networks https://ec.europa.eu/health/sites/health/files/ern/docs/2017_brochure_en.pdf, last Accessed 3rd October 2019.

  4. Bradnock TJ, Knight M, Kenny S, et al. on behalf of the British Association of Pediatric Surgeons Congenital Anomalies Surveillance System. Hirschprung’s disease in the UK and Ireland: incidence and anomalies. Arch Dis Child. 2017;102:722–7.

    CAS  PubMed  Google Scholar 

  5. Russell MB, Russell CA, Niebuhr E. An epidemiological study of Hirschsprung’s disease. Acta Paediatr. 1994;83:68–71.

    CAS  PubMed  Google Scholar 

  6. Duess JW, Hofmann AD, Puri P. Prevalence of Hirschsprung’s disease in premature infants: a systematic review. Pediatr Surg Int. 2014;30:791–5.

    PubMed  Google Scholar 

  7. Stensrud KJ, Emblem R, Bjornland K. Late diagnosis of Hirschsprung’s disease – patient characteristics and results. J Pediatr Surg. 2012;47:1874–9.

    PubMed  Google Scholar 

  8. Hernandez DG, Plesec T. Hirschsprung disease and use of calretinin in inadequate rectal suction biopsies. Arch Pathol Lab Med. 2013;137:1099–102.

    Google Scholar 

  9. Knowles CH, De Giorgio R, Kapur RP, et al. The London classification of gastrointestinal neuromuscular pathology: report on behalf of the Gastro 2009 International Working Group. Gut. 2010;59:882–7.

    PubMed  Google Scholar 

  10. Schäppi MG, Staiano A, Milla PJ, et al. A practical guide for the diagnosis of primary enteric nervous system disorders. J Pediatr Gastroenterol Nutr. 2013;57:677–86.

    PubMed  Google Scholar 

  11. Jeong H, Jung HR, Hwang I, et al. Diagnostic accuracy of combined acetylcholinesterase histochemistry and calretinin immunohistochemistry of rectal biopsy specimens in Hirschsprung’s disease. Int J Surg Pathol. 2018;26:507–13.

    CAS  PubMed  Google Scholar 

  12. Guinard-Samuel V, Bonnard A, De Lagausie P, et al. Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung disease. Mol Pathol. 2009;22:1379–84.

    CAS  Google Scholar 

  13. Moore SW, Johnson G. Acetylcholinesterase in Hirschsprung’s disease. Pediatr Surg Int. 2005;21:255–63.

    CAS  PubMed  Google Scholar 

  14. Janssen Lok M, Rassouil-Kirchmeier R, Köster N, et al. Development of nerve fiber diameter in young infants with Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2018;66:253–6.

    PubMed  Google Scholar 

  15. de Lorijn F, Kremer LCM, Reitsma JB, et al. Diagnostic tests in Hirschsprung disease: A systematic review. J Pediatr Gastroenterol Nutr. 2006;42:496–505.

    PubMed  Google Scholar 

  16. Allen AR, Putnam AR, Presson AP, et al. The accuracy of suction rectal biopsy for the diagnosis of Hirschsprung’s disease. Eur J Pediatr Surg. 2018. https://doi.org/10.1055/s-0038-1667040 [Epub ahead of print].

  17. Schmiedeke E, de Blaauw I, Lacher M, et al. Towards the perfect ARM center: the European Union’s criteria for centers of expertise and their implementation in the member states. A report from the ARM-Net. Pediatr Surg Int. 2015;31:741–5.

    CAS  PubMed  Google Scholar 

  18. Pakarinen MP, Bjornland K, Qvist N, et al. Centralized pediatric surgery in the Nordic countries: A role model for Europe? Eur J Pediatr Surg. 2017;27:395–8.

    PubMed  Google Scholar 

  19. Durkin N, Davenport M. Centralization of pediatric surgical procedures in the United Kingdom. Eur J Pediatr Surg. 2017;27:410–5.

    Google Scholar 

  20. Lampela H, Ritvanen A, Kosola S, et al. National centralization of biliary atresia care to an assigned multidisciplinary team provides high-quality outcomes. Scand J Gastroenterol. 2012;47:99–107.

    PubMed  Google Scholar 

  21. Volanthen R, Lodge P, Barkun JS, et al. Toward a consensus on centralization in surgery. Ann Surg. 2018;268:712–4.

    Google Scholar 

  22. Ward ST, Dimick JB, Zhang W, et al. Association between hospital staffing models and failure to rescue. Ann Surg. 2018. https://doi.org/10.1097/SLA.0000000000002744 [Epub ahead of print].

  23. Neuvonen MI, Kyrklund K, Rintala RJ, et al. Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg. 2017;52:622–9.

    Google Scholar 

  24. Ralls MW, Freeman JJ, Rabah R, et al. Redo pullthrough for Hirschsprung disease: a single surgical group’s experience. J Pediatr Surg. 2014;49:1394–9.

    PubMed  Google Scholar 

  25. Dindo D, Demartines N, Clavien PA. Classification of surgical complications:a new proposal with evaluation in a cohort of 6336 patients and resultsof a survey. Ann Surg. 2004;240:205–13.

    PubMed  PubMed Central  Google Scholar 

  26. Vallejo-Torres L, Melnychuk M, Vindrola-Padros C, et al. Discrete-choice experiment to analyse preferences for centralizing specialist cancer surgery services. Br J Surg. 2018;105:587–96.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Wester T, Granström AL. Hirschsprung disease- bowel function beyond childhood. Semin Pediatr Surg. 2017;26:322–7.

    PubMed  Google Scholar 

  28. Bjornland K, Pakarinen MP, Stenstrom P, et al. A Nordic multicenter survey of long-term bowel function after transanal endorectal pull-through in 200 patients with rectosigmoid Hirschsprung disease. J Pediatr Surg. 2017;52(9):1458–64.

    PubMed  Google Scholar 

  29. Langer JC, Rollins MD, Levitt M, et al. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung’s disease. Pediatr Surg Int. 2017;33:523–6.

    CAS  PubMed  Google Scholar 

  30. Hukkinen M, Koivusalo A, Rintala RJ, et al. Restorative proctocolectomy with J-pouch ileoanal anastomosis for total colonic aganglianosis among neonates and infants. J Pediatr Surg. 2014;49:570–4.

  31. Zani A, Eaton S, Morini F, et al. European Pediatric Surgeons’ Association survey on the management of Hirschsprung Disease. Eur J Pediatr Surg. 2017;27:96–101.

    PubMed  Google Scholar 

  32. Nelson RL, Gladman E, Barbateskovic M. Antimicrobial prophylaxis for colorectal surgery. Cochrane Database Syst Rev. 2014; 9: CD001181. doi: https://doi.org/10.1002/14651858.CD001181.pub4, last accessed 29th December 2018.

  33. Rangel SJ, Islam S, St Peter SD, et al. Prevention of infectious complications after elective colorectal surgery in children: an American Pediatric Surgical Association outcomes and clinical trials committee comprehensive review. J Pediatr Surg. 2015;50:192–200.

    PubMed  Google Scholar 

  34. Keckler SJ, Yang JC, Fraser JD, et al. Contemporary practice patterns in the surgical management of Hirschsprung's disease. J Pediatr Surg. 2009;44(6):1257–60.

    PubMed  Google Scholar 

  35. Georgeson KE. Laparoscopic-assisted pull-through for Hirschsprung's disease. Semin Pediatr Surg. 2002;11(4):205–10.

    PubMed  Google Scholar 

  36. Tomuschat C, Zimmer J, Puri P. Laparoscopic-assisted pull-through operation for Hirschsprung's disease: a systematic review and meta-analysis. Pediatr Surg Int. 2016;32(8):751–7.

    CAS  PubMed  Google Scholar 

  37. Antao B, Roberts J. Laparoscopic-assisted transanal endorectal coloanal anastomosis for Hirschsprung's disease. J Laparoendosc Adv Surg Tech A. 2005;15(1):75–9.

    PubMed  Google Scholar 

  38. Nah SA, de Coppi P, Kiely EM, et al. Duhamel pull-through for Hirschsprung disease: a comparison of open and laparoscopic techniques. J Pediatr Surg. 2012;47(2):308–12.

    PubMed  Google Scholar 

  39. Tannuri AC, Tannuri U, Romao RL. Transanal endorectal pull-through in children with Hirshsprung disease: Refinements and comparison of results with the Duhamel procedure. J Pediatr Surg. 2009;44:767–72.

    PubMed  Google Scholar 

  40. El-Sawaf MI, Drongowski RA, Chamberlain JN, et al. Are the long-term results of the transanal pull-through equal to those of the transabdominal pull-through? A comparison of the 2 approaches for Hirschsprung disease. J Pediatr Surg. 2007;42(1):41–7.

    PubMed  Google Scholar 

  41. Minford JL, Ram A, Turnock RR, et al. Comparison of functional outcomes of Duhamel and transanal endorectal coloanal anastomosis for Hirschsprung's disease. J Pediatr Surg. 2004;39(2):161–5.

    CAS  PubMed  Google Scholar 

  42. Mao YZ, Tang ST, Li S. Duhamel operation vs. transanal endorectal pull-through procedure for Hirschsprung disease: A systematic review and meta-analysis. J Pediatr Surg. 2018;53(9):1710–5.

    PubMed  Google Scholar 

  43. Seo S, Miyake H, Hock A, et al. Duhamel and Transanal Endorectal Pull-throughs for Hirschsprung' Disease: A Systematic Review and Meta-analysis. Eur J Pediatr Surg. 2018;28(1):81–8.

    PubMed  Google Scholar 

  44. Stensrud KJ, Emblem R, Bjørnland K. Anal endosonography and bowel function in patients undergoing different types of endorectal pull-through procedures for Hirschsprung disease. J Pediatr Surg. 2015;50:1341–6.

    PubMed  Google Scholar 

  45. Van Leeuwen K, Geiger JD, Barnett JL, et al. Stooling and manometric findings after primary pull-throughs in Hirschsprung's disease: Perineal versus abdominal approaches. J Pediatr Surg. 2002;37(9):1321–5.

    PubMed  Google Scholar 

  46. Arts E, Botden SMB, Lacher M, et al. Duhamel versus transanal endorectal pull through (TERPT) for the surgical treatment of Hirschsprung’s disease. Tech coloproctol. 2016;20:677–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. De la Torre L, Ortega A. Transanal versus open endorectal pull-through for Hirschsprung’s disease. J Pediatr Surg. 2000;35:1630–2.

    PubMed  Google Scholar 

  48. Nasr A, Langer JC. Evolution of the technique in the transanal pull-through for Hirschsprung's disease: effect on outcome. J Pediatr Surg. 2007;42(1):36–9.

    PubMed  Google Scholar 

  49. Miyano G, Takeda M, Koga H, et al. Hirschsprung's disease in the laparoscopic transanal pull-through era: implications of age at surgery and technical aspects. Pediatr Surg Int. 2018;34(2):183–8.

    PubMed  Google Scholar 

  50. Yang L, Tang ST, Cao GQ, et al. Transanal endorectal pull-through for Hirschsprung's disease using long cuff dissection and short V-shaped partially resected cuff anastomosis: early and late outcomes. Pediatr Surg Int. 2012;28(5):515–21.

    PubMed  Google Scholar 

  51. Rintala RJ. Transanal coloanal pull-through with a short muscular cuff for classic Hirschsprung's disease. Eur J Pediatr Surg. 2003;13(3):181–6.

    CAS  PubMed  Google Scholar 

  52. Levitt MA, Hamrick MC, Eradi B, et al. Transanal, full-thickness, Swenson-like approach for Hirschsprung disease. J Pediatr Surg. 2013;48(11):2289–95.

    PubMed  Google Scholar 

  53. Elhalaby EA, Hashish A, Elbarbary MM, et al. Transanal one-stage endorectal pull-through for Hirschsprung's disease: a multicenter study. J Pediatr Surg. 2004;39(3):345–51 discussion -51.

    PubMed  Google Scholar 

  54. Yamataka A, Kaneyama K, Fujiwara N, et al. Rectal mucosal dissection during transanal pull-through for Hirschsprung disease: the anorectal or the dentate line? J Pediatr Surg. 2009;44(1):266–9.

    PubMed  Google Scholar 

  55. Lawal TA, Chatoorgoon K, Collins MH, et al. Redo pull-through in Hirschsprung's disease for obstructive symptoms due to residual aganglionosis and transition zone bowel. J Pediatr Surg. 2011;46(2):342–7.

    PubMed  Google Scholar 

  56. Short HL, Heiss KF, Burch K, et al. Implementation of an enhanced recovery protocol in pediatric colorectal surgery. J Pediatr Surg. 2018;53:688–92.

    PubMed  Google Scholar 

  57. Heiss KF, Raval MV. Patient engagement to enhance recovery for children undergoing surgery. Semin Pediatr Surg. 2018;27:86–91.

    PubMed  Google Scholar 

  58. Wester T, Rintala RJ. Early outcome of transanal endorectal pull-through with a short muscle cuff during the neonatal period. J Pediatr Surg. 2004;39:157–60.

    CAS  PubMed  Google Scholar 

  59. Seo S, Miyake H, Hock A, et al. Duhamel and Transanal Endorectal Pull-throughs for Hirschsprung’s Disease: Review and Meta-analysis. Eur J Pediatr Surg. 2018;28:81–8.

    PubMed  Google Scholar 

  60. Aworanti O, Hung J, McDowell D, et al. Are routine dilatations necessary post pull-through surgery for Hirschsprung disease? Eur J Pediatr Surg. 2013;23:383–8.

    PubMed  Google Scholar 

  61. Temple SJ, Shawyer A, Langer JC. Is daily dilatation by parents necessary after surgery for Hirschsprung disease and anorectal malformations? J Pediatr Surg. 2012;47:209–12.

    PubMed  Google Scholar 

  62. Kyrklund K, Neuvonen MI, Pakarinen MP, et al. Social morbidity in relation to bowel functional outcomes in anorectal malformations and Hirschsprung’s disease. Eur J Pediatr Surg. 2018;28:522–8.

    PubMed  Google Scholar 

  63. Meinds RJ, van der Steeg AFW, Sloots CEJ, et al. Long-term functional outcomes and quality of life in patients with Hirschsprung’s disease. Br J Surg. 2019;106:499–507.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Witvliet MJ, van Gasteren S, van den Hondel D, et al. Predicting sexual problems in young adults with an anorectal malformation or Hirschsprung disease. J Pediatr Surg. 2018 Aug;53(8):1555–9.

    CAS  PubMed  Google Scholar 

  65. Veras LV, Chotai PN, Tumen AZ, et al. Impaired growth outcomes in children with congenital colorectal diseases. J Surg Res. 2018 Sep;229:102–7.

    PubMed  PubMed Central  Google Scholar 

  66. Onishi S, Nakame K, Kaji T, et al. The bowel function and quality of life of Hirschsprung disease patients who have reached 18 years of age or older – the long-term outcomes after undergoing the transabdominal soave procedure. J Pediatr Surg. 2017;52:2001–5.

    PubMed  Google Scholar 

  67. Rintala RJ, Pakarinen MP. Long-term outocomes of Hirschsprung’s disease. Semin Pediatr Surg. 2012;21:336–43.

    PubMed  Google Scholar 

  68. Salamanca-Balen N, Seymour J, Caswell G, et al. The costs, resource use and cost-effectiveness of clinical nurse specialist-led interventions for patients with palliative care needs: A systematic review of international evidence. Palliat Med. 2018;32:447–65.

    PubMed  Google Scholar 

  69. Nah SA, Ong CCP, Lie D, et al. Understanding experiences of youth growing up with anorectal malformation or Hirschsprung’s disease to inform transition of care: A qualitative in-depth interview study. Eur J Pediatr Surg. 2018;28:67–74.

    PubMed  Google Scholar 

  70. Cairo SB, Chiu PPL, Dasgupta R, et al. American Academy of Pediatrics Section on Surgery's Delivery of Surgical Care Committee. Transitions in care from pediatric to adult general surgery: Evaluating an unmet need for patients with anorectal malformation and Hirschsprung disease. J Pediatr Surg. 2018;53:1566–72.

    PubMed  Google Scholar 

  71. Hartman EE, Oort FJ, Sprangers MA, et al. Factors affecting quality of life of children and adolescents with anorectal malformations or Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2008;47:463–71.

    PubMed  Google Scholar 

  72. Hartman EE, Oort FJ, Aronson DC, et al. Quality of life and disease-specific functioning of patients with anorectal malformations or Hirschsprung's disease: a review. Arch Dis Child. 2011 Apr;96(4):398–406.

    CAS  PubMed  Google Scholar 

  73. Wittmeier KDM, Hobbs-Murison K, Holland C, et al. Identifying information needs for Hirschsprung disease through caregiver involvement via social media: a prioritization study and literature review. J Med Internet Res. 2018;20:e297.

    PubMed  PubMed Central  Google Scholar 

  74. NICE guideline (NG43). (2016) Transition from childrens’ to adults’ services for young people using health or social care services. https://www.nice.org.uk/guidance/ng43, last accessed July 2019.

  75. Frykman PK, Short S. Hirschsprung-associated enterocolitis: prevention and therapy. Semin Pediatr Surg. 2012;21:328–35.

  76. Pastor AC, Osman F, Teitelbaum DH, et al. Development of a standardized definition for Hirschsprung-associated enterocolitis: a Delphi analysis. J Pediatr Surg. 2009;44:251–6.

  77. Gosain A, Frykman PK, Cowles RA, et al. Guidelines for the diagnosis and management of Hirschsprung associated enterocolitis. Pediatr Surg Int. 2017;33:517–21.

    PubMed  PubMed Central  Google Scholar 

  78. Langer JC, Rollins MD, Levitt M, et al. American Pediatric Surgical Association Hirschsprung Disease Interest Group. Guidelines for the management of postoperative obstructive symptoms in children with Hirschsprung disease. Pediatr Surg Int. 2017;33:523–6.

    CAS  PubMed  Google Scholar 

  79. Gosain A, Brinkman AS. Hirschsprung’s associated enterocolitis. Curr Opin Pediatr. 2015;27:364–49.

    PubMed  PubMed Central  Google Scholar 

  80. Halleran DR, Lu PL, Ahmad H, et al. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications. J Pediatr Surg. 2019. https://doi.org/10.1016/j.jpedsurg.2019.03.020 [Epub ahead of print].

  81. Han-Geurts IJM, Hendrix VC, de Baauw I, et al. Outcome after anal intrasphincteric botox injection in children with surgically treated Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2014;59:604–7.

    CAS  PubMed  Google Scholar 

  82. Louis-Borrione C, Faure A, Garnier S, et al. Neurostimulation-guided anal intrasphincteric botulinum toxin injection in children with Hirschsprung Disease. J Pediatr Gastroenterol Nutr. 2019;68:527–32.

    CAS  PubMed  Google Scholar 

  83. Wester T, Granström AL. Botulinum toxin is efficient to treat obstructive symptoms in children with 77 Hirschsprung disease. Pediatr Surg Int. 2015;31:255–9.

  84. Patrus B, Nasr LJC, et al. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease. J Pediatr Surg. 2011;46:184–7.

    PubMed  Google Scholar 

  85. Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2011;53:75–9.

    PubMed  Google Scholar 

  86. Koivusalo AI, Pakarinen MP, Rintala RJ. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschaprung disease. Pediatr Surg Int. 2009;25:873–6.

    CAS  PubMed  Google Scholar 

  87. Frykman PK, Nordenskjöld A, Kawaguchi A, et al. Characterization of bacterial and fungal microbiome in children with Hirschsprung disease with and without a history of enterocolitis: A multicenter study. PLoS One. 2015;10(4):e0124172.

    PubMed  PubMed Central  Google Scholar 

  88. Yan Z, Poroyko V, Gu S, et al. Characterization of the intestinal microbiome of Hirschsprung's disease with and without enterocolitis. Biochem Biophys Res Commun. 2014;445(2):269–74.

    CAS  PubMed  Google Scholar 

  89. Li Y, Poroyoko V, Yan Z, et al. Characterization of intestinal microbiomes of Hirschsprung’s disease patients with or without enterocolitis using illumina Mi-Seq High-Throughput Sequencing. PLoS One. 2016;11:e0162079.

    PubMed  PubMed Central  Google Scholar 

  90. Neuvonen MI, Korpela K, Kyrklund K, et al. Intestinal Microbiota in Hirschsprung Disease. J Pediatr Gastroenterol Nutr. 2018;67:594–600.

    PubMed  Google Scholar 

  91. El-Sawaf M, Siddiqui S, Mahmoud M, et al. Probiotic prophylaxis after pullthrough for Hirschsprung disease to reduce incidence of enterocolitis: A prospective, randomized, double-blind, placebo-controlled, multicenter trial. J Pediatr Surg. 2013;48:111–7.

    PubMed  Google Scholar 

  92. Wang X, Li Z, Xu Z, et al. Probiotics prevent Hirschsprung’s disease-associated enterocolitis: a prospective multicenter randomized controlled trial. Int J Color Dis. 2015;30:105–10.

    Google Scholar 

  93. Nakamura H, Lim T, Puri P. Probiotics for the prevention of Hirschsprung-associated enterocolitis: a systematic review and meta-analysis. Pediatr Surg Int. 2018;34:189–93.

    CAS  PubMed  Google Scholar 

  94. Granström AL, Amin L, Arnell H, et al. Increased risk of inflammatory bowel disease in a population-based cohort-study of patients with Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2018;66:398–401.

    Google Scholar 

  95. Zimmer J, Tomuschat C, Puri P. Long-term results of transanal pull-through for Hirschsprung's disease: a meta-analysis. Pediatr Surg Int. 2016;32(8):743–9. https://doi.org/10.1007/s00383-016-3908-z Epub 2016 Jul 6.

    CAS  Article  PubMed  Google Scholar 

  96. Granström AL, Danielson J, Husberg B, et al. Adult outcomes after surgery for Hirschsprung's disease: Evaluation of bowel function and quality of life. J Pediatr Surg. 2015;50(11):1865–9. https://doi.org/10.1016/j.jpedsurg.2015.06.014 Epub 2015 Jun 24.

    Article  PubMed  Google Scholar 

  97. Dasgupta R, Langer JC. Evaluation and management of persistent problems after surgery for Hirschsprung disease in a child. J Pediatr Gastroenterol Nutr. 2008;46:13–9.

    PubMed  Google Scholar 

  98. Koppen IJ, von Gontard A, Chase J, et al. Management of functional nonretentive fecal incontinence in children: Recommendations from the International Children's Continence Society. J Pediatr Urol. 2016;12:56–64.

    CAS  PubMed  Google Scholar 

  99. Keshtgar AS, Ward HC, Clayden GS, et al. Investigations for incontinence and constipation after surgery for Hirschsprung's disease in children. Pediatr Surg Int. 2003;19(1-2):4–8 Epub 2002 Nov 14.

    CAS  PubMed  Google Scholar 

  100. Bischoff A, Frischer J, Knod JL, et al. Damaged anal canal as a cause of fecal incontinence after surgical repair for Hirschsprungdisease - a preventable and under-reported complication. J Pediatr Surg. 2017;52(4):549–53.

    PubMed  Google Scholar 

  101. Ralls MW, Coran AG, Teitelbaum DH. Reoperative surgery for Hirschsprung disease. Semin Pediatr Surg. 2012;21:354–63.

    PubMed  Google Scholar 

  102. Dickie BH, Webb KM, Eradi B, et al. The problematic Soave cuff in Hirschsprung disease: manifestations and treatment. J Pediatr Surg. 2014;49(1):77–80.

    PubMed  Google Scholar 

  103. Obermayr F, Hacker HW, Bornemann W, et al. Redo-endorectal pull through following various pull through procedures in Hirschsprung's disease. Langenbeck's Arch Surg. 2008;393:493–9.

    Google Scholar 

  104. Friedmacher F, Puri P. Residual aganglionosis after pull-through operation for Hirschsprung’s disease: A systematic review and meta-analysis. Pediatr Surg Int. 2011;27:1053–7.

    PubMed  Google Scholar 

  105. Dingemans AJM, van der Steeg HJJ, Rassouli-Kirchmeier R, et al. Redo pull-through surgery in Hirschsprung disease: Short-term clinical outcome. J Pediatr Surg. 2017;52:1446–50.

    PubMed  Google Scholar 

  106. Edery P, Lyonnet S, Mulligan LM, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367:378–80.

    CAS  PubMed  Google Scholar 

  107. Romeo G, et al. 1994 Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 1994;367:377–8.

    CAS  PubMed  Google Scholar 

  108. Hofstra RM, Wu Y, Stulp RP, et al. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat. 2000;15:418–29.

    CAS  PubMed  Google Scholar 

  109. Attie T, Pelet A, Edery P, et al. Diversity of RET proto-oncogene mutations in familial and sporadic Hirschsprung disease. Hum Mol Genet. 1995;4:1381–6.

    CAS  PubMed  Google Scholar 

  110. Pasini B, Borrello MG, Greco A, et al. Loss of function effect of RET mutations causing Hirschsprung disease. Nat Genet. 1995;10:35–40.

    CAS  PubMed  Google Scholar 

  111. Virtanen VB, Pukkala E, Kivisaari R, et al. Thyroid cancer and co-occurring RET mutations in Hirschsprung’s disease. Eur J Med Genet. 2018. https://doi.org/10.1016/j.ejmg.2018.07.019 [Epub ahead of print].

  112. Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet. 2008;45:1–14.

    CAS  PubMed  Google Scholar 

  113. Sijmons RH, Hofstra RM, Wijburg FA, et al. Oncological implications of RET gene mutations in Hirschsprung's disease. Gut. 1998;43:542–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  114. Mulligan LM, Kwok JB, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature. 1993;363:458–60.

    CAS  PubMed  Google Scholar 

  115. Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet. 1993;2:851–6.

    CAS  PubMed  Google Scholar 

  116. Jakobson-Setton A, Weissmann-Brenner A, Achiron R, et al. Retrospective analysis of prenatal ultrasound of children with Hirschsprung disease. Prenat Diagn. 2015;35:699–702.

    CAS  PubMed  Google Scholar 

  117. Neuvonen M, Kyrklund K, Taskinen S, et al. Lower urinary tract symptoms and sexual functions after endorectal pull-through for Hirschsprung disease: controlled long-term outcomes. J Pediatr Surg. 2017 Aug;52(8):1296–301.

    PubMed  Google Scholar 

  118. Shannon A, Eng K, Kay M, et al. Long-term follow-up of ileal pouch anal anastomosis in a large cohort of pediatric and young adult patients with ulcerative colitis. J Pediatr Surg. 2016;51:1181–6.

    PubMed  Google Scholar 

  119. European Commission: ERN assessment manual for applicants. 4- Operational Criteria for the assessment of Healthcare Providers http://ec.europa.eu/research/participants/data/ref/other_eu_prog/hp/guide/pse/hp-asses-manual-ern-op-criteria-hc-providers_en.pdf, last accessed 6th December 2018.

  120. Canadian Task Force on the Periodic Health Exmination: Task Force Report. CMA Journal 1979; 121: 1193-1254.

  121. Brouwers M, Kho ME, Browman GP, et al. on behalf of the AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. Can Med Assoc J. 2010;182:E839–42. https://doi.org/10.1503/cmaj.090449.

    Article  Google Scholar 

  122. Andrews J, Guyatt G, Oxman AD, et al. GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. J Clin Epidemiol. 2013;66:719–25.

    PubMed  Google Scholar 

  123. Canadian Task Force on Preventitive Health Care. Putting prevention into practice. GRADE: Grades of Recommendation, Development, Assessment and Evaluation. https://canadiantaskforce.ca/wp-content/uploads/2016/05/grade-en.pdf, last accessed 8th December 2018.

  124. Forbes A, Escher J, Hebuterne X, et al. ESPEN guideline: Clinical nutrition and inflammatory bowel disease. Clin Nutr. 2017;36:321–47.

    PubMed  Google Scholar 


Page 2

Biopsies should be evaluated by an experienced consultant histopathologist, seeking external consultation if necessary • The presence of any number of ganglion cells on hematoxylin and eosin (H&E) staining excludes HSCR. • If ganglion cells are not seen, additional histologic evaluation should be considered before setting a diagnosis of HSCR. • Calretinin and/or peripherin should be used to look for ganglion cells, particularly in premature infants where these are small and not well visualised on H&E. • In HSCR, acetylcholinesterase activity is increased, and calretinin immunohistochemistry is negative.

(Within Europe, external consultation can be requested from an ERNICA centre. A Clinical Patient Management System e-platform is under development)